Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: ContraBand™: Safety & Feasibility Study (RM-20-01) [NA]

View source ↗

Summary

This document provides an update on ContraBand™, a safety and feasibility study (RM-20-01) sponsored by Restore Medical Ltd. The trial targets left-sided heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ContraBand™

Snippet

Sponsor: Restore Medical Ltd | Conditions: Heart Failure, Left Sided | NA | Status: RECRUITING